The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy

Epilepsy and Behavior

Volumn 13, Issue 2, 2008, Pages 279-283

  Scorza, Fulvio A ^a   Cysneiros, Roberta M ^d   Arida, Ricardo M ^a   Terra Bustamante, Vera C ^b   de Albuquerque, Marly ^c   Cavalheiro, Esper A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro de Cirurgia de Epilepsia CIREP   (Brazil)

^c UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^d MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

Author keywords

Epilepsy; Heart; Omega 3 fatty acids; Sudden death; SUDEP

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO;

CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG SAFETY; ENVIRONMENTAL FACTOR; EPILEPSY; HEART ARRHYTHMIA; HEREDITY; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; REVIEW; SEIZURE; SIDE EFFECT; SOCIAL ASPECT; SUDDEN DEATH; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; EPILEPSY; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 45849093642     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.04.011     Document Type: Review

References (54)

1. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 16 (2003) 165-170
2. Annegers J.F. Epidemiology of epilepsy. In: Wyllie E. (Ed). The treatment of epilepsy: principles and practice. 2nd ed. (1997), Williams & Wilkins, Baltimore 165-172
3. Yuen A.W., and Sander J.W. Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP? A hypothesis. Seizure 13 (2004) 104-107
4. Sander J.W. Some aspects of prognosis in the epilepsies: a review. Epilepsia 34 (1993) 1007-1016
5. Kwan P., and Sander J.W. The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 75 (2004) 1376-1381
6. Halatchev V.N. Epidemiology of epilepsy: recent achievements and future. Fol Med (Plovdiv) 42 (2000) 17-22
7. Duncan J.S., Sander J.W., Sisodiya S.M., and Walker M.C. Adult epilepsy. Lancet 367 (2006) 1087-1100
8. Babb T.L. Synaptic reorganizations in human and rat hippocampal epilepsy. Adv Neurol 79 (1999) 763-779
9. Engel Jr. J. Update on surgical treatment of the epilepsies. Summary of the Second International Palm Desert Conference on the Surgical Treatment of the Epilepsies. Neurology 43 (1993) 1612-1617
10. Cendes F., Leproux F., Melanson D., Ethier R., Evans A., Peters T., et al. MRI of amygdala and hippocampus in temporal lobe epilepsy. J Comput Assist Tomogr 17 (1993) 206-210
11. Tomson T., Walczak T., Sillanpaa M., and Sander J.W. Sudden unexpected death in epilepsy: a review of incidence and risk factors. Epilepsia 46 (2005) 54-61
12. Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 38 (1997) S6-S8
13. Leestma J.E., Annegers J.F., Brodie M.J., et al. Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia 38 (1997) 47-55
14. Tennis P., Cole T.B., Annegers J.F., Leestma J.E., McNutt M., and Rajput A. Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada. Epilepsia 36 (1995) 29-36
15. Nashef L., Fish D.R., Sander J.W., and Shorvon S.D. Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatry 58 (1995) 462-464
16. Ficker D.M., So E.L., Shen W.K., et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 515 (1998) 1270-1274
17. Lhatoo S.D., Langan Y., MacDonald B.K., Zeidan S., and Sander J.W. Sudden unexpected death: a rare event in a large community based prospective cohort with newly diagnosed epilepsy and high remission rates. J Neurol Neurosurg Psychiatry 66 (1999) 692-693
18. Medical Research Council, Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 1991;337:1175-80.
19. Nilsson L., Farahmand B.Y., Persson P.G., Thiblin I., and Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 353 (1999) 888-893
20. Walczak T.S., Leppik I.E., D'Amelio M., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56 (2001) 519-525
21. Sperling M.R., Feldman H., Kinman J., Liporace J.D., and O'Connor M.J. Seizure control and mortality in epilepsy. Ann Neurol 46 (1999) 45-50
22. Langan Y., Nashef L., and Sander J.W. Case-control study of SUDEP. Neurology 64 (2005) 1131-1133
23. Kloster R., and Engelskjon T. Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors. J Neurol Neurosurg Psychiatry 67 (1999) 439-444
24. Scorza F.A., Albuquerque M., Arida R.M., and Cavalheiro E.A. Sudden unexpected death in epilepsy: are winter temperatures a new potential risk factor?. Epilepsy Behav 10 (2007) 509-510
25. Lathers C.M., Schraeder P.L., and Bungo M.W. The mystery of sudden death: mechanisms for risks. Epilepsy Behav 12 (2008) 3-24
26. Lathers C.M., and Schraeder P.L. Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity. Epilepsia 23 (1982) 633-647
27. Dyerberg J., and Bang H.O. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2 (1979) 433-435
28. Gudbjarnason S., and Hallgrimsson J. Prostaglandins and polyunsaturated fatty acids in heart muscle. Acta Biol Med Geriatr 35 (1976) 1069-1080
29. McLennan P.L., Bridle T.M., Abeywardena M.Y., and Charnock J.S. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J 123 (1992) 1555-1561
30. McLennan P.L. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 57 (1993) 207-212
31. Yang B.C., Saldeen T.G., Bryant J.L., Nichols W.W., and Mehta J.L. Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am Heart J 126 (1993) 1287-1292
32. Jacobsen A.N., Du X.J., Dart A.M., and Woodcock E.A. Ins(1,4,5)P3 and arrhythmogenic responses during myocardial reperfusion: evidence for receptor specificity. Am J Physiol 273 (1997) H1119-H1125
33. Billman G.E., Hallaq H., and Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 91 (1994) 4427-4430
34. Billman G.E., Kang J.X., and Leaf A. Prevention of ischemia-induced cardiac sudden death by n -3 polyunsaturated fatty acids in dogs. Lipids 32 (1997) 1161-1168
35. Kang J.X., and Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 91 (1994) 9886-9890
36. Kang J.X., and Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids: recent studies. Circulation 94 (1996) 1774-1780
37. + channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 92 (1995) 11000-11004
38. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 94 (1997) 4182-4187
39. + channels. Am J Physiol Heart Circ Physiol 279 (2000) H35-H46
40. Leaf A., Kang J.X., Xiao Y.F., and Billman G.E. Clinical prevention of sudden cardiac death by n -3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n -3 fish oils. Circulation 107 (2003) 2646-2652
41. Albert C.M., Hennekens C.H., O'Donnell C.J., et al. Fish consumption and risk of sudden cardiac death. JAMA 279 (1998) 23-28
42. Siscovick D.S., Lemaitre R.N., and Mozaffarian D. The fish story: a diet-heart hypothesis with clinical implications: n -3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death. Circulation 107 (2003) 2632-2634
43. Marchioli R., and for the GISSI-Prevenzione Investigators. Results of GISSI-Prevenzione: diet, drugs, and cardiovascular risk. Cardiologia 44 (1999) 745-746
44. Marchioli R., Barzi F., Bomba E., et al., for the GISSI-Prevenzione Investigators. Early protection against sudden death by n -3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
45. Stollberger C., and Finsterer J. Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP). Epilepsy Res 59 (2004) 51-60
46. Calder P.C. n -3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci 107 (2004) 1-11
47. Voskuyl R.A., Vreugdenhil M., Kang J.X., and Leaf A. Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 341 (1998) 145-152
48. Xiao Y., and Li X. Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 846 (1999) 112-121
49. Ferrari D, Cysneiros RM, Scorza CA, et al. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical analysis for calcium-binding proteins. Epilepsy Behav 2008, in press. Available online 4 March 2008.
50. Schlanger S., Shinitzky M., and Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43 (2002) 103-104
51. Colugnati D.B., Gomes P.A., Arida R.M., et al. Analysis of cardiac parameters in animals with epilepsy: possible cause of sudden death?. Arq Neuropsiquiatr 23 (2005) 1035-1041
52. Yuen A.W., Sander J.W., Flugel D., et al. Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations?. Epilepsy Behav 12 (2008) 317-323
53. Gaby A.R. Natural approaches to epilepsy. Altern Med Rev 12 (2007) 9-24
54. Mazza M., Pomponi M., Janiri L., Bria P., and Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 12-26